Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines for Health Centers (First Edition) - Ethiopia (DACA; 2004; 240 pages)
View the documentACKNOWLEDGEMENTS
View the documentFOREWORD
View the documentCHAPTER 1. INTRODUCTION
Open this folder and view contentsCHAPTER 2. INFECTIOUS DISEASES
Open this folder and view contentsCHAPTER 3. SEXUALLY TRANSMITTED DISEASES
Open this folder and view contentsCHAPTER 4. COMMON SKIN PROBLEMS
close this folderCHAPTER 5. NON-INFECTIOUS DISEASES
Open this folder and view contentsCardiovascular diseases
Open this folder and view contentsCentral nervous system
Open this folder and view contentsGastrointestinal conditions
Open this folder and view contentsMusculoskeletal conditions
Open this folder and view contentsNutritional and haematologic conditions
Open this folder and view contentsRespiratory diseases
close this folderOther non-infectious diseases
View the documentNAUSEA AND VOMITING
Open this folder and view contentsCHAPTER 6. OBSTETRICS AND GYNECOLOGICAL CONDITIONS
Open this folder and view contentsCHAPTER 7. PEDIATRIC DISEASES
Open this folder and view contentsCHAPTER 8. /EMERGENCY CONDITIONS
View the documentANNEXES
 

NAUSEA AND VOMITING

Nausea refers to the feeling of an imminent desire to vomit where as vomiting refers to the forceful oral expulsion of gastric contents. They may occur independently of each other but generally are closely related. They are common manifestations of many organic and functional disorders. One should therefore look for and correct any underlying causes. Effective therapy usually depends on correction of the underlying cause.

Treatment

Non-drug treatment:

Removal of the underlined cause, correct dehydration, if any


Drug treatment:

First line

Meclizine hydrochloride, 25-50mg. p.o

S/E: sedation.

C/I: active work such as deriving

Dosage forms: Tablets, 12.5mg, 25mg


Alternative

Metoclopramide, 10mg, p.o. tid or im or iv 1 - 3 times a day. For children: maximum 0.5 mg/kg daily

(For S/E, C/I and Dosage forms, see page 129)


OR

Chlorpromazine, 12.5 - 25 mg IM 12 hrly.

S/E: bone marrow suppression, drowsiness, apathy, alteration in liver function, cutaneous reactions, occasionally tardive dyskinesia.

C/I: bone marrow depression, coma caused by CNS v depressants.

Dosage forms:tablet, 25mg, 50mg, 100mg; drop, 25mg/ml in 10ml bottle, 40mg/ml in 10ml and 30ml bottles; syrup, 25mg/5ml; injection, 25mg/ml in 1ml and 2ml ampoules, 50mg/ml in 2ml ampoule.

to previous sectionto next section

Please provide your feedback English  |  French